wega breakfast: AI powered disease modelling in real world for value based clinical development
Drug development has been undergoing a transformational shift from the classical sequence of randomized control trials (RCT) to a more agile process capitalizing better and faster from past trials and real-world data. This shift has been accelerated and reinforced by the COVID pandemic which highlighted the critical need for robust real-world data platforms and fit-for-purpose analytical tools.
The purpose of this talk is to propose a regulatory-grade, data-integrative and disease-centric approach to accelerate and de-risk trials while maximizing the real-world value of the products in development.
https://www.wega-it.com/wega-breakfas...